The 10-year-old spine firm initiated its initial public offering this month, transforming from the largest private spine device firm to another public player in a highly competitive market. CEO Eric Major K2M’s focus on complex spinal deformities will help distinguish it from the pack.
Link:
K2M Funds Its Focus On The Complex Spine With IPO
Tags: diagnostics, qdss